Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification

Autor: Snell, KIE, Ward, DG, Gordon, NS, Goldsmith, JC, Sutton, AJ, Patel, P, James, ND, Zeegers, MP, Cheng, KK, Bryan, RT

Publikováno v: Oncotarget

Objectives: To investigate whether elevated urinary HAI-1, EpCAM and EGFR are independent prognostic biomarkers within non-muscle-invasive bladder cancer (NMIBC) patients, and have utility for risk stratification to facilitate treatment decisions. Re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::c4c35839ca42b9b59174d4f0e1c24ec1

Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint.

Autor: Servais, Laurent^1,2 (AUTHOR) laurent.servais@paediatrics.ox.ac.uk, Strijbos, Paul³ (AUTHOR), Poleur, Margaux⁴ (AUTHOR), Mirea, Andrada^5,6 (AUTHOR), Butoianu, Nina⁷ (AUTHOR), Sansone, Valeria A.⁸ (AUTHOR), Vuillerot, Carole⁹ (AUTHOR), Schara-Schmidt, Ulrike¹⁰ (AUTHOR), Scoto, Mariacristina¹¹ (AUTHOR), Seferian, Andreea M.¹² (AUTHOR), Previtali, Stefano C.¹³ (AUTHOR), Tulinius, Már¹⁴ (AUTHOR), Nascimento, Andrés^15,16 (AUTHOR), Furlong, Pat¹⁷ (AUTHOR), Singh, Teji¹⁸ (AUTHOR), Dreghici, Roxana Donisa¹⁹ (AUTHOR), Goemans, Nathalie²⁰ (AUTHOR), Mercuri, Eugenio^21,22 (AUTHOR), Straub, Volker²³ (AUTHOR), Ormazabal, Maitea Guridi²⁴ (AUTHOR)

Publikováno v: Scientific Reports. 11/29/2024, Vol. 14 Issue 1, p1-12. 12p.

Operational description of rare diseases: a reference to improve the recognition and visibility of rare diseases.

Autor: Wang, Chiuhui Mary¹ (AUTHOR) mary.wang@rarediseasesint.org, Whiting, Amy Heagle¹ (AUTHOR), Rath, Ana² (AUTHOR), Anido, Roberta³ (AUTHOR), Ardigò, Diego⁴ (AUTHOR), Baynam, Gareth⁵ (AUTHOR), Dawkins, Hugh⁶ (AUTHOR), Hamosh, Ada⁷ (AUTHOR), Le Cam, Yann⁸ (AUTHOR), Malherbe, Helen^9,10 (AUTHOR), Molster, Caron M.¹¹ (AUTHOR), Monaco, Lucia¹² (AUTHOR), Padilla, Carmencita D.¹³ (AUTHOR), Pariser, Anne R.¹² (AUTHOR), Robinson, Peter N.¹⁴ (AUTHOR), Rodwell, Charlotte² (AUTHOR), Schaefer, Franz¹⁵ (AUTHOR), Weber, Stefanie¹⁶ (AUTHOR), Macchia, Flaminia¹ (AUTHOR)

Publikováno v: Orphanet Journal of Rare Diseases. 9/11/2024, Vol. 19 Issue 1, p1-6. 6p.

Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification.

Autor: Snell KIE; Centre for Prognosis Research, Research Institute for Primary Care and Health Science, Keele University, Newcastle-under-Lyme, ST5 5BG, UK., Ward DG; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK., Gordon NS; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK., Goldsmith JC; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK., Sutton AJ; Leeds Institute of Health Sciences, University of Leeds and The Diagnostic Evidence Cooperative, Leeds LS2 9JT, UK., Patel P; Institute of Cancer and Genomic Sciences, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2TH, UK., James ND; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK., Zeegers MP; NUTRIM School for Nutrition and Translational Research in Metabolism and CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht 6200 MD, The Netherlands., Cheng KK; Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK., Bryan RT; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.

Publikováno v: Oncotarget [Oncotarget] 2018 May 18; Vol. 9 (38), pp. 25244-25253. Date of Electronic Publication: 2018 May 18 (Print Publication: 2018).

Rare disease clinical trials in the European Union: navigating regulatory and clinical challenges.

Autor: Mishra, Sangita¹ (AUTHOR), Venkatesh, MP^1,2 (AUTHOR) venkateshmpv@jssuni.edu.in

Publikováno v: Orphanet Journal of Rare Diseases. 7/31/2024, Vol. 19 Issue 1, p1-19. 19p.